T. Rowe Price Associates, Inc. 13D and 13G filings for Kodiak Sciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | KODIAK SCIENCES INC KOD | T. Rowe Price Associates, Inc. | 3,248,611 5.200% | 2,776,598 (+588.25%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | KODIAK SCIENCES INC KOD | T. Rowe Price Associates, Inc. | 472,013 0.900% | -2,213,734 (-82.43%) | Filing |
| 2022-03-10 12:48 pm Sale | 2022-02-28 | 13G | KODIAK SCIENCES INC KOD | T. Rowe Price Associates, Inc. | 2,685,747 5.100% | -5,430,715 (-66.91%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | KODIAK SCIENCES INC KOD | T. Rowe Price Associates, Inc. | 8,116,462 15.600% | 1,940,251 (+31.41%) | Filing |